We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$204M
AUM Growth
-$18.2M
Cap. Flow
-$10.3M
Cap. Flow %
-5.06%
Top 10 Hldgs %
45.6%
Holding
87
New
21
Increased
21
Reduced
13
Closed
30

Top Buys

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$7.45M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.35M
3
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$5.22M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$4.72M
5
ADPT
Adeptus Health Inc
ADPT
+$4.38M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$12.4M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$9.5M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$5.94M
4
ILMN icon
Illumina
ILMN
+$5.24M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$4.5M

Sector Composition

Rank Sector Weight
1 Healthcare 30.04%
2 Consumer Discretionary 17.07%
3 Communication Services 10.51%
4 Materials 9.25%
5 Industrials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PARA
51
CALL
DELISTED
Paramount Global Class B
PARA
$655K 0.32%
16,400
– –
LLY icon
52
Eli Lilly
LLY
$991B
$628K 0.31%
+7,500
New +$633K
VTAE
53
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$495K 0.24%
+45,000
New +$478K
ENPH icon
54
CALL
Enphase Energy
ENPH
$5.53B
$370K 0.18%
+100,000
New +$532K
W icon
55
CALL
Wayfair
W
$15.2B
$364K 0.18%
+10,400
New +$399K
ACAD icon
56
CALL
Acadia Pharmaceuticals
ACAD
$4.59B
$331K 0.16%
10,000
-7,000
-41% -$291K
IMUX icon
57
PUT
Immunic
IMUX
$194M
$168K 0.08%
+104
New +$520K
ABBV icon
58
AbbVie
ABBV
$432B
– –
-61,850
Closed -$4.16M
AGIO icon
59
Agios Pharmaceuticals
AGIO
$1.89B
– –
-5,950
Closed -$662K
ALNY icon
60
Alnylam Pharmaceuticals
ALNY
$29B
– –
-24,000
Closed -$2.88M
AMN icon
61
AMN Healthcare
AMN
$1.3B
– –
-25,500
Closed -$805K
ATRO icon
62
Astronics
ATRO
$3.74B
– –
-68,166
Closed -$2.65M
BLUE
63
DELISTED
bluebird bio
BLUE
– –
-1,467
Closed -$3.2M
BLUE
64
PUT
DELISTED
bluebird bio
BLUE
– –
-556
Closed -$1.21M
CI icon
65
Cigna
CI
$72.1B
– –
-26,500
Closed -$4.29M
CNC icon
66
Centene
CNC
$31.7B
– –
-78,000
Closed -$3.13M
CSTE icon
67
Caesarstone
CSTE
$78.8M
– –
-21,000
Closed -$1.44M
DIS icon
68
Walt Disney
DIS
$170B
– –
-22,550
Closed -$2.57M
ESPR
69
CALL
DELISTED
Esperion Therapeutics
ESPR
– –
-18,300
Closed -$1.5M
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
– –
-8,000
Closed -$654K
HUM icon
71
Humana
HUM
$43.5B
– –
-20,000
Closed -$3.83M
ILMN icon
72
Illumina
ILMN
$30.4B
– –
-24,672
Closed -$5.24M
JAZZ icon
73
Jazz Pharmaceuticals
JAZZ
$16.3B
– –
-17,000
Closed -$2.99M
LULU icon
74
lululemon athletica
LULU
$13.9B
– –
-35,000
Closed -$2.29M
RARE icon
75
Ultragenyx Pharmaceutical
RARE
$2.53B
– –
-10,400
Closed -$1.06M
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Atika Capital Management held 87 positions worth $204M, down 8.2% from $222M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Atika Capital Management withdrew a net $10.3M in Q3 2015, closing 30 positions and reducing 13 holdings. Its most notable exit was RECEPTOS INC COM STK (DE), an estimated $9.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Atika Capital Management opened a new position in Advance Auto Parts worth $8.15M.

  • Atika Capital Management's largest Q3 2015 buy was Advance Auto Parts: 43,000 shares worth $8.15M.
  • Atika Capital Management added most to Alphabet (Google) Class C in Q3 2015, an estimated $5.35M increase.
  • Atika Capital Management's biggest Q3 2015 reduction was Netflix, cutting an estimated $12.4M.
  • Atika Capital Management fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $9.5M.
  • Atika Capital Management's ten largest holdings make up 46% of its $204M portfolio in Q3 2015.
  • Atika Capital Management opened 21 new positions and closed 30 in Q3 2015.
  • Atika Capital Management's portfolio value fell 8.2% quarter-over-quarter to $204M.

Based on Atika Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.